Loading AVIR charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading AVIR comparable companies…
| AVIRAtea Pharmaceuticals, Inc.(opens in a new tab) | $0.33B | $0.35B | +622.5% | — | — | — | — |
|---|---|---|---|---|---|---|---|
| XERSXeris Biopharma Holdings, Inc.(opens in a new tab) | $1.85B | $0.34B | +36.3% | 86.6% | 10.9% | 5.52× | — |
| PHARPharming Group N.V.(opens in a new tab) | $0.91B | $0.38B | +26.6% | 87.9% | 6.9% | 2.41× | 303.0× |
| AUPHAurinia Pharmaceuticals Inc.(opens in a new tab) | $2.25B | $0.32B | +21.0% | 90.6% | 48.6% | 7.00× | 7.3× |
| SVASinovac Biotech Ltd(opens in a new tab) | — | $0.39B | +6.8% | 67.9% | −127.0% | — | — |
| Medianpeers, excl. AVIR | $1.85B | $0.36B | +23.8% | 87.2% | 8.9% | 5.52× | 155.1× |